Outcomes of Surgical Management for Parathyroid Adenomas

Overview

Journal Indian J Otolaryngol Head Neck Surg

Publisher Springer

Date 2023 Nov 17

PMID 37974675

Authors

Gargi Dhingani

Akshat Malik

Vikram Singh

Harit Chaturvedi

Rohit Nayyar

Affiliations

Soon will be listed here.

Abstract

Aim: Descriptive analysis of patients undergoing parathyroid adenoma surgery at a tertiary care hospital.

Methodology: Patients with parathyroid adenoma operated from January 2016 to December 2020. Serum calcium and PTH were used to establish the diagnosis. Ultrasonography (USG) studies localized the adenoma. NIH criteria was used for decision regarding surgery. Patients were analyzed with regards to pre operative localization, biochemical monitoring and other outcomes.

Results: Of the 15 eligible patients, all were symptomatic, with myalgia (34%) being the commonest symptom. Rome criteria confirmed the adequacy of the procedure by measuring intra operative drop in PTH. Average decrease in serum PTH level was 69.9% and serum calcium was 20.6% after excision of adenoma. The average size of excised adenoma was 2.5 cm. There were no post operative complications and all patients were normocalcemic on follow up.

Conclusion: Parathyroidectomy is a simple, safe and effective solution that reduces the morbidity of symptomatic primary hyperparathyroidism patients. Pre operative localization studies affirm the diagnosis and intra operative biochemical confirmation clinches the adequacy of resection.

References

Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Espinosa De Ycaza A, Jasim S, Castaneda-Guarderas A . Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. World J Surg. 2016; 40(10):2359-77. DOI: 10.1007/s00268-016-3514-1. View

Westerdahl J, Lindblom P, Valdemarsson S, Tibblin S, Bergenfelz A . Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg. 2000; 135(2):142-7. DOI: 10.1001/archsurg.135.2.142. View

Singh Ospina N, Maraka S, Rodriguez-Gutierrez R, Espinosa De Ycaza A, Jasim S, Gionfriddo M . Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis. Osteoporos Int. 2016; 27(12):3395-3407. DOI: 10.1007/s00198-016-3715-3. View

Cetani F, Marcocci C, Torregrossa L, Pardi E . Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors. Endocr Relat Cancer. 2019; 26(7):R441-R464. DOI: 10.1530/ERC-19-0135. View

Khan A, Bilezikian J . Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ. 2000; 163(2):184-7. PMC: 80211. View

Arya A, Kumari P, Bhadada S, Agrawal K, Singh P, Mukherjee S . Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry. J Bone Miner Metab. 2020; 39(2):253-259. DOI: 10.1007/s00774-020-01142-w. View

Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W . Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg. 2009; 394(5):843-9. DOI: 10.1007/s00423-009-0510-z. View

Petranovic Ovcaricek P, Giovanella L, Carrio Gasset I, Hindie E, Huellner M, Luster M . The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021; 48(9):2801-2822. PMC: 8263421. DOI: 10.1007/s00259-021-05334-y. View

Pallan S, Rahman M, Khan A . Diagnosis and management of primary hyperparathyroidism. BMJ. 2012; 344:e1013. DOI: 10.1136/bmj.e1013. View

10.

Witteveen J, van Thiel S, Romijn J, Hamdy N . Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2012; 168(3):R45-53. DOI: 10.1530/EJE-12-0528. View

11.

Lou I, Balentine C, Clarkson S, Schneider D, Sippel R, Chen H . How long should we follow patients after apparently curative parathyroidectomy?. Surgery. 2016; 161(1):54-61. PMC: 5164956. DOI: 10.1016/j.surg.2016.05.049. View

12.

Eigelberger M, Cheah W, Ituarte P, Streja L, Duh Q, Clark O . The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?. Ann Surg. 2004; 239(4):528-35. PMC: 1356258. DOI: 10.1097/01.sla.0000120072.85692.a7. View

13.

Uden P, Chan A, Duh Q, Siperstein A, Clark O . Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery. World J Surg. 1992; 16(4):791-7; discussion 798. DOI: 10.1007/BF02067389. View

14.

Calo P, Pisano G, Loi G, Medas F, Barca L, Atzeni M . Intraoperative parathyroid hormone assay during focused parathyroidectomy: the importance of 20 minutes measurement. BMC Surg. 2013; 13:36. PMC: 3848580. DOI: 10.1186/1471-2482-13-36. View

15.

Mihai R, Palazzo F, Gleeson F, Sadler G . Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. Br J Surg. 2006; 94(1):42-7. DOI: 10.1002/bjs.5574. View